9258 Wealth Management, LLC Eli Lilly & CO Transaction History

9258 Wealth Management, LLC

$641 Million
Q2 2024

A detailed history of 9258 Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, 9258 Wealth Management, LLC holds 5,126 shares of LLY stock, worth $4.66 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

5,126

Previous 5,173 0.91%

Holding current value

$4.66 Million

Previous $4.02 Million 15.31%

% of portfolio

0.72%

Previous 0.63%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$724.87 - $909.04 $34,068 - $42,724	-47 Reduced 0.91%	5,126 $4.64 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $27,833 - $37,237	47 Added 0.92%	5,173 $4.02 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $3,151 - $3,714	-6 Reduced 0.12%	5,126 $2.99 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $78,246 - $107,873	-180 Reduced 3.39%	5,132 $2.76 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $9,820 - $13,131	28 Added 0.53%	5,312 $2.49 Million
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $81,074 - $95,218	261 Added 5.2%	5,284 $1.81 Million
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $164,312 - $191,456	511 Added 11.33%	5,023 $1.84 Million
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $54,255 - $61,830	183 Added 4.23%	4,512 $1.46 Million
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $50,450 - $59,235	-181 Reduced 4.01%	4,329 $1.4 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $26,285 - $32,665	-112 Reduced 2.42%	4,510 $1.29 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $14,390 - $17,858	-64 Reduced 1.37%	4,622 $1.28 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $7,091 - $8,726	-32 Reduced 0.68%	4,686 $1.08 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $4,333 - $5,604	24 Added 0.51%	4,718 $1.08 Million
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $53,404 - $69,134	325 Added 7.44%	4,694 $877,000
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $10,436 - $13,810	80 Added 1.87%	4,369 $738,000
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $44,158 - $51,077	-302 Reduced 6.58%	4,289 $560,000
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $2,046 - $2,462	15 Added 0.33%	4,591 $754,000
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $18,809 - $23,281	-158 Reduced 3.34%	4,576 $738,000
Q4 2019 Feb 06, 2020	BUY	$106.92 - $132.43 $506,159 - $626,923	4,734 New	4,734 $622,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 9258 Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 9258 Wealth Management, LLC with notifications on news.

Account

9258 Wealth Management, LLC Eli Lilly & CO Transaction History